NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637113. A total of 33 filers reported holding NABRIVA THERAPEUTICS PLC in Q2 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.
Quarter-by-quarter ownership
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 191,028 | $317,000 | 0.06% |
FRAZIER MANAGEMENT LLC | 425,650 | $707,000 | 0.06% |
Values First Advisors, Inc. | 45,033 | $75,000 | 0.06% |
SABBY MANAGEMENT, LLC | 164,007 | $272,000 | 0.05% |
ABG Innovation Capital Partners III GP Ltd | 45,849 | $76,000 | 0.04% |
CCG WEALTH MANAGEMENT, LLC | 10,480 | $17,000 | 0.02% |
Virtu Financial LLC | 31,186 | $52,000 | 0.00% |
KESTRA PRIVATE WEALTH SERVICES, LLC | 31,274 | $52,000 | 0.00% |
WINTON GROUP Ltd | 33,211 | $55,000 | 0.00% |
Squarepoint Ops LLC | 156,623 | $260,000 | 0.00% |